Ingevity Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.7% | -8.5% | +14.8% | -3.5% | -20.7% | -5.0% | +28.6% | -8.8% | -23.4% | +1.1% | +21.7% | – | |
| – | -1.5% | -23.0% | +11.2% | -7.6% | -20.3% | -13.4% | +33.2% | -12.3% | -16.0% | -15.4% | +23.7% | – | |
| – | -53.9% | +67.6% | +23.6% | +5.4% | -21.6% | +11.3% | +21.6% | -2.9% | -34.4% | +32.6% | +19.4% | – | |
| – | -7.7% | -5.6% | +7.4% | -8.2% | +9.0% | +5.5% | +1.3% | -10.3% | +5.7% | -9.5% | -9.0% | – | |
| – | +8.5% | +8.8% | -12.3% | -6.5% | +1.8% | +9.4% | +2.6% | -0.2% | -5.7% | -2.2% | -4.2% | – | |
| – | -60.8% | +6.7% | -9.8% | -6.8% | +2.9% | +8.8% | +2.4% | -1.7% | -4.1% | -3.3% | +66.5% | – | |
| – | -89.0% | +413.5% | +63.0% | +13.4% | -34.7% | +13.4% | +37.2% | -3.6% | -53.1% | +77.8% | -12.9% | – | |
| – | +9.7% | -10.7% | +3.4% | +1.7% | +4.1% | -18.4% | -5.3% | -1.5% | -13.9% | +1.8% | -16.5% | – | |
| – | -579.8% | – | – | – | – | +204.5% | -632.5% | – | -269.3% | – | +67.9% | – | |
| – | -639.1% | – | – | – | – | – | -39.7% | +463.2% | -223.8% | – | +60.3% | – | |
| – | -563.5% | – | – | – | – | +23.5% | -814.6% | – | -294.5% | – | -41.0% | – | |
| – | -218.8% | – | – | – | – | +21.8% | -233.9% | – | -157.3% | – | +12.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.